Eli Lilly ( NYSE: LLY) has filed lawsuits against four telehealth platforms that the pharma giant alleges are selling ...

Share on Pinterest The FDA’s new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Images Provided by ...

fueled by the demand for diabetes and weight loss drugs, known generically as tirzepatide and semaglutide. The suit challenges a key strategy that has allowed compounding pharmacies to continue to ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

As the Food and Drug Administration cracks down on compounded versions of popular weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide), Americans who rely on these cheaper medications ...

Counterfeit forms of weight loss and diabetes drugs are ... Gower said she does not do "sterile compounding," so she doesn't compound semaglutide or tirzepatide. "The issue is that the companies ...

That spells bad news for manufacturers of compounded semaglutide and the telehealth companies that have built up a market selling cheaper alternatives to branded weight loss drugs. The U.S. allows ...

The drug is the key ingredient in the blockbuster diabetes and weight-loss medications Ozempic ... reported that people were overdosing on compounded semaglutide. That means “a lot of nausea ...

Novo Nordisk, the pharmaceutical giant that makes Ozempic and Wegovy, emphasizes there is no generic semaglutide currently ... What to do if you rely on compounded weight-loss drugs There are ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...